scholarly journals Transurethral Electric Coagulation Combined With Retroperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Urothelial Carcinoma

2015 ◽  
Vol 100 (3) ◽  
pp. 547-551 ◽  
Author(s):  
Jiantao Wang ◽  
Shengqiang Yu ◽  
Changping Men ◽  
Chunhua Lin ◽  
Zhiyu Zhang ◽  
...  
Keyword(s):  
Hospital Stay ◽  
Urothelial Carcinoma ◽  
Recurrence Rate ◽  
Tumor Recurrence ◽  
Test Group ◽  
Operation Time ◽  
Upper Urinary Tract ◽  
Control Group ◽  
Tumor Recurrence Rate ◽  
Laparoscopic Nephroureterectomy

Retroperitoneal laparoscopic nephroureterectomy (LNU) combined with transurethral electric resection of ipsilateral bladder cuff is widely accepted to treat the upper urinary tract urothelial carcinoma (UUT-UC). To reduce the local recurrence rate, we improved the procedure from electric resection to electric coagulation. From May 2008 to July 2012, of all the 156 retroperitoneal LNU patients, 76 cases (test group) were performed with LNU combined with electric coagulation, and 80 cases (control group) were with electric resection. For the clinical outcomes, the hospital stay in the test group was shorter (5.2 ± 2.6 days versus 8.2 ± 3.4 days; P < 0.05), and the 1-year tumor recurrence rate was much lower (1.6% versus 13.3%, P < 0.05). There was no difference in operation time and blood loss between groups. Retroperitoneal LNU combined with electric coagulation is technically feasible and safe with lower tumor recurrence rate and shorter hospital stay.

scholarly journals Open Nephroureterectomy Compared to Laparoscopic in Upper Urinary Tract Urothelial Carcinoma: A Meta-Analysis

2021 ◽  
Vol 8 ◽  
Author(s):  
Guihong Liu ◽  
Zeqin Yao ◽  
Guoqiang Chen ◽  
Yalang Li ◽  
Bing Liang
Keyword(s):  
Urinary Tract ◽  
Blood Loss ◽  
Urothelial Carcinoma ◽  
Meta Analysis ◽  
Operation Time ◽  
Upper Urinary Tract ◽  
Efficacy And Safety ◽  
Lower Blood ◽  
Urinary Tract Urothelial Carcinoma ◽  
Laparoscopic Nephroureterectomy

Background: In this meta-analysis, we will focus on evaluating the effects of open nephroureterectomy compared with laparoscopic nephroureterectomy on postoperative results in upper urinary tract urothelial carcinoma subjects.Methods: A systematic literature search up to January 2021 was performed, and 36 studies included 23,013 subjects with upper urinary tract urothelial carcinoma at the start of the study; of them, 8,178 were laparoscopic nephroureterectomy, and 14,835 of them were open nephroureterectomy. They were reporting relationships between the efficacy and safety of open nephroureterectomy compared with laparoscopic nephroureterectomy in the treatment of upper urinary tract urothelial carcinoma. We calculated the odds ratio (OR) or the mean difference (MD) with 95% CIs to evaluate the efficacy and safety of open nephroureterectomy compared with laparoscopic nephroureterectomy in the treatment of upper urinary tract urothelial carcinoma using the dichotomous or continuous method with a random or fixed-effect model.Results: Laparoscopic nephroureterectomy in subjects with upper urinary tract urothelial carcinoma was significantly related to longer operation time (MD, 43.90; 95% CI, 20.91–66.90, p < 0.001), shorter hospital stay (MD, −1.71; 95% CI, −2.42 to −1.00, p < 0.001), lower blood loss (MD, −133.82; 95% CI, −220.92 to −46.73, p = 0.003), lower transfusion need (OR, 0.56; 95% CI, 0.47–0.67, p < 0.001), and lower overall complication (OR, 0.79; 95% CI, 0.70–0.90, p < 0.001) compared with open nephroureterectomy.However, no significant difference was found between laparoscopic nephroureterectomy and open nephroureterectomy in subjects with upper urinary tract urothelial carcinoma in 2–5 years recurrence-free survival (OR, 0.90; 95% CI, 0.69–1.18, p = 0.46), 2–5 years cancer-specific survival (OR, 0.94; 95% CI, 0.69–1.28, p = 0.68), and 2–5 years overall survival (OR, 1.31; 95% CI, 0.91–1.87, p = 0.15).Conclusion: Laparoscopic nephroureterectomy in subjects with upper urinary tract urothelial carcinoma may have a longer operation time, shorter hospital stay, and lower blood loss, transfusion need, and overall complication compared to open nephroureterectomy. Further studies are required to validate these findings.

scholarly journals Complete Transperitoneal Laparoscopic Nephroureterectomy in a Single Position with Upper Urinary Tract Urothelial Carcinoma and Comparative Outcomes

2021 ◽  
Author(s):  
chengwu xiao ◽  
Yang Wang ◽  
Meimian Hua ◽  
Wei Zhang ◽  
Guanyu Ren ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Blood Loss ◽  
Urothelial Carcinoma ◽  
Length Of Hospital Stay ◽  
Operation Time ◽  
Tumor Grade ◽  
Upper Urinary Tract ◽  
Significant Difference ◽  
Urinary Tract Urothelial Carcinoma ◽  
Laparoscopic Nephroureterectomy

Abstract Background: To describe techniques for complete transperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma (UTUC) with a single position and here to report our outcomes. Materials and methods: Between January 2016 and June 2019, our group performed 50 complete transperitoneal laparoscopic nephroureterectomy (CTLNU) and 48 laparoscopic nephroureterectomy with open bladder cuff excision (LNOBE) for UTUC without metastases in our group. The clinical data were collected and analyzed retrospectively. Results: All 98 patients of radical nephroureterectomy performance were successfully without transferred into open surgery. No significant difference was found in patient’s clinical characteristics. Compare with LNOBE group, the CTLNU group had shorter operative time(98.5±40.3min vs 132.4±60.2min), less blood loss(60.4±20.3ml vs 150.6±50.2ml), shorter length of hospital stay(5.3±2.2d vs 8.1±2.3d), and shorter length of incision(6.3±1.2cm vs 11.5±3.2cm). Pathological stage, tumor grade, recurrence rate was similar between these two groups. Conclusions: Complete transperitoneal laparoscopic nephroureterectomy(CTLNU) in a single position had advantages of shorter operation time, less blood loss, and shorter incision length. This operative method could minimize invasive and accelerate recovery of patients which deserved clinical application and promotion.

scholarly journals LASER ABLATION FOR PILONIDAL DISEASE

2020 ◽  
Vol 19 (2) ◽  
pp. 91-103
Author(s):  
D. A. Khubezov ◽  
R. V. Lukanin ◽  
A. R. Krotkov ◽  
A. Y. Ogoreltsev ◽  
P. V. Serebryansky ◽  
...  
Keyword(s):  
Laser Ablation ◽  
Postoperative Pain ◽  
Hospital Stay ◽  
Recurrence Rate ◽  
Pilonidal Sinus ◽  
Pilonidal Disease ◽  
Main Group ◽  
Cosmetic Result ◽  
Control Group ◽  
Primary Wound Closure

AIM: to evaluate short-term results of pilonidal disease treatment using different methods: the excision of pilonidal sinus and fistula with open wound healing, the primary closure of the wound and the laser ablation (2017-2019).PATIENTS AND METHODS: ninety patients with pilonidal disease without abscess were included in the comparative non-randomized study. The control group included 30 patients with excision and open wound healing. The first main group included 30 patients with the excision of pilonidal sinus and fistula with primary wound closure. The second main group included 30 patients with laser ablation of pilonidal sinus and fistula. The evaluation criteria included gender, age, BMI, number of previous procedures, operative time, hospital stay, postoperative pain intensity (VAS), cosmetic result (VAS), complication rate and recurrence rate.RESULTS: all three groups were homogeneous in gender, age, BMI. The control group showed no complications (р<0.0001) and no recurrence (р<0.0001) rate but had more intensive pain (mean 5.9 points; р<0.0001) and worse cosmetic result (mean 4.4 points; р<0.0001). The group with primary wound closure (1st main group) had the highest complication rate (23.4%; р=0.004) and recurrence rate (16.7%; р=0.02). The group with laser ablation had significantly shorter hospital stay (1.1 days; р<0.0001), good cosmetic result (mean 8.9 points; р<0.0001) and less postoperative pain (1.4 points; р<0.0001) with low recurrence rate (3.3%; p=0.32).CONCLUSION: the laser ablation of pilonidal sinus and fistula provides less postoperative pain intensity and low recurrence rate, better cosmetic result and short hospital stay. It can be used for outpatient treatment.

Long-Term Outcome of Hand-Assisted Laparoscopic Nephroureterectomy for Pathologic T3 Upper Urinary Tract Urothelial Carcinoma

2009 ◽  
Vol 23 (1) ◽  
pp. 75-80 ◽  
Author(s):  
Shiu-Dong Chung ◽  
Shyh-Chyan Chen ◽  
Shuo-Meng Wang ◽  
Shih-Chieh Chueh ◽  
Ming-Kuen Lai ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urothelial Carcinoma ◽  
Upper Urinary Tract ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Urinary Tract Urothelial Carcinoma ◽  
Laparoscopic Nephroureterectomy

Effect of asymptomatic recurrence detection after nephroureterectomy on prognosis in patients with upper urinary tract urothelial carcinoma.

2016 ◽  
Vol 34 (2_suppl) ◽  
pp. 364-364
Author(s):  
Shingo Hatakeyama ◽  
Takahiro Yoneyama ◽  
Yasuhiro Hashimoto ◽  
Takuya Koie ◽  
Chikara Ohyama
Keyword(s):  
Overall Survival ◽  
Urinary Tract ◽  
Urothelial Carcinoma ◽  
Tumor Recurrence ◽  
Patient Survival ◽  
Upper Urinary Tract ◽  
Symptomatic Recurrence ◽  
The Impact ◽  
Urinary Tract Urothelial Carcinoma

364 Background: It is unknown whether routine follow up with body computed tomography (CT) to detect asymptomatic visceral recurrence after nephroureterectomy improves patient survival. We accessed the impact of follow up with body CT on patient survival after nephroureterectomy. Methods: A total 212 nephroureterectomy for upper urinary tract urothelial carcinoma were performed at our hospital between Feb 1995 and Oct 2015. All patients had regular follow up with chest x-ray, urine cytology and cystoscopy every 3 to 6 months, blood biochemical test, and CT of the chest and abdomen every 6 to 12 months. Additional examinations were required for symptomatic recurrence. We investigated the first site and date of tumor recurrence. Overall survival in patients with recurrence stratified by the mode of diagnosis (asymptomatic vs. symptomatic) was estimated using the Kaplan-Meier methods and compared with the log rank test. Cox proportional hazard regression models were used to evaluate the impact of the mode of diagnosing recurrence on survival. Results: A total 43 patients (20%) experienced recurrence after surgery, of whom 31 (72%) were asymptomatic and 12 (28%) were symptomatic. The most common symptoms at recurrence were pain in 7, hematuria in 2 , appetite loss in 1 , edema in 1 , palpable mass in 1, general malaise in 1 patients. Overall survival was not significantly different between in patients with asymptomatic vs. symptomatic recurrence; however, survival after tumor recurrence were better in patients with asymptomatic recurrence (P = 0.033). Moreover, multivariate analysis showed symptomatic recurrence was selected as a risk factor for overall survival after recurrence. Conclusions: Routine oncological follow up after nephroureterectomy for early detection of asymptomatic visceral recurrence was associated with patient survival. Further study is necessary to establish the optimal follow up regimen balancing the benefit of asymptomatic detection with the increased cost of routine surveillance.

Sign in / Sign up

Export Citation Format

Share Document